Donanemab in Early Alzheimer’s Disease
In patients with early Alzheimer's disease, donanemab resulted in a better composite score for cognition and for the ability to perform activities of daily living than placebo a...
Publications
View AllAffiliated Researchers
Institution Info
- Type
- company
- Country
- SG
- Publications
- 2
- Citations
- 1,482
External Links
Identifiers
- ROR
- https://ror.org/010ajwv03